sábado, 6 de septiembre de 2025

FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss?utm_medium=email&utm_source=govdelivery

No hay comentarios: